Apotheek Mann SPRL
2.2 FTEThe score of Apotheek Mann shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +14 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Mann's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 147,671 € | ||||
| Equity | 358,394 € | ||||
| Cash | 19,637 € | ||||
| EBITDA | 250,979 € | ||||
| Total assets | €1.09m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 06 Jul 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 07 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Apotheek Mann's financial analysis
- Solvency32.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Mann
Apotheek Mann's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0815.855.617
- VAT number
- BE0815855617
- Peppol
- Registered · 0208:0815855617 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 26 Jun 2009
- Registered office
- 2018 Antwerp
- Size
- Micro · 2.2 FTE
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Mann (SPRL) has been based in Antwerp since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 147,671 € and equity of 358,394 €; its revenue is not published. With 2.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 32.8%, below the median of its sector (44.2%).
Companies similar to Apotheek Mann
Companies in the same business, of comparable size and area, outside its group.
- Meta Invest & Consult Retail sale of pharmaceutical products Antwerp · balance sheet €1.11m
- Pharmacie P. Leroy Retail sale of pharmaceutical products Engis · balance sheet €1.09m
- Fardil Retail sale of pharmaceutical products Dilbeek · balance sheet €1.10m
- Holsbeek Brasschaat Retail sale of pharmaceutical products Brasschaat · balance sheet €1.10m
- P. Corstiens Farma Retail sale of pharmaceutical products Westerlo · balance sheet €1.09m
- Stediphar Retail sale of pharmaceutical products Ostend · balance sheet €1.09m
- Ap. Pharmamax Retail sale of pharmaceutical products Boom · balance sheet €1.09m
- Assentfarma Retail sale of pharmaceutical products Bekkevoort · balance sheet €1.08m
Frequently asked questions about Apotheek Mann
What is the revenue of Apotheek Mann?
Apotheek Mann files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Mann?
In Belgium, the VAT number is the company number prefixed with BE: BE0815855617 for Apotheek Mann, if the company is VAT-registered. Its company number (CBE) is 0815.855.617.
Where is the registered office of Apotheek Mann?
According to the CBE register, the registered office of Apotheek Mann is in 2018 Antwerp.
What is the equity of Apotheek Mann?
At the close of the 2025 financial year, the equity of Apotheek Mann amounts to 358,394 €, a solvency of 32.8% of total assets.
How many people work at Apotheek Mann?
2.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Mann?
The register lists 2 active mandates at Apotheek Mann. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Mann
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →